Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Addictions
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Addictions
    Varenicline Effective in Smoking Cessation for Smokers With Chronic Diseases: Presented at ERS - (DGDispatch)
    TopAbstracts in Addictions 10/02/2008 - (DGNews)
    TopAbstracts in Addictions 09/18/2008 - (DGNews)
    TopAbstracts in Addictions 09/04/2008 - (DGNews)
    Implantable Naltrexone More Effective Than Oral Formulation in Heroin Addiction: Presented at ECNP - (DGDispatch)

    News archive

     Recent webcasts/CME - Addictions
      Fetal Alcohol Spectrum Disorders (FASD): What it as and How it Affects the Child, the Family and Society: FASD and its Effects II
      Fetal Alcohol Spectrum Disorders (FASD): What it is and How it Affects the Child, the Family and Society: FASD and its Effects I
      More Than Brief Intervention: Updating Smoking Cessation Treatment for Pulmonary Patients
      Balanced Opioid Prescribing
      Opioid Addiction: No Reason to Withhold Pain Management

      Webcasts/CME archive

       Recent cases - Addictions
        Rare Case of Cefotaxime Induced Leukocytoclastic Vasculitis in Alcoholic Cirrhosis Patient
        Cystitis Due to the Use of Ketamine as a Recreational Drug: A Case Report
        Decrease in Tobacco Consumption After Treatment with Topiramate and Aripiprazole
        Calcific Myofibrosis Due to Pentazocine Abuse: A Case Report
        A Novel SPINK1 Gene Mutation, c.206C>T, in a Thai Patient with Chronic Alcoholic Pancreatitis

        Cases archive
          




        my personal edition > addictions > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Calcium Channel Blockers Effective In Opiate Withdrawal

        A DGReview of :"Nimodipine in opiate detoxification: a controlled trial"
        Addiction

        08/13/2002
        By Harvey McConnell


        Calcium channel blockers appear to offer a more effective and comfortable technique for opiate detoxification when compared with more conventional regimens.

        Based on their findings with the use of calcium channel blockers, compared with controls groups receiving nimodipine and dextropropoxiphen, or beta- 2-adrenergic agents and naltrexone, researchers think the findings now warrant a randominised controlled trial.

        Dr. Juan Manuel Jiménez-Lerma and colleagues at the Addiction Treatment Center of Alva and other colleagues in the Basque Health Service, Vitoria-Gasteiz, Spain, evaluated the use of L-type calcium channel blockers over seven days at out-patient opiate detoxification clinics.

        Thirty patients received a course of nimodipine and dextropropoxiphen. One control group of 20 patients received a course of dextropropoxiphen and benzodiazepine; and a second control group of 30 patients received a standard course of beta-2-adrenergic agents and naltrexone. In all groups, detoxification was scheduled over seven days.

        Dr Jiménez-Lerma and colleagues found that all of the patients had a pattern of significant opiate withdrawal symptoms during detoxification. Starting from the first day, however, patients treated with calcium channel blockers displayed fewer withdrawal symptoms than patients in the two control groups.

        Intensity of the opiate withdrawal was reduced by 50 percent in the patients receiving calcium channel blockers compared with the intensity of withdrawal displayed by the two control groups.

        Clinicians had the impression that detoxification was comfortable in all three groups of patients and free of complications. In addition, they did not observe any significant side effects from any of the regimens.
        Addiction Volume 97 Issue 7 Page 819. "Nimodipine in opiate detoxification: a controlled trial"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send